The context and approach for the California newborn screening short- and long-term follow-up data system: Preliminary findings

被引:21
作者
Feuchtbaum, Lisa [1 ]
Dowray, Sunaina [2 ]
Lorey, Fred [1 ]
机构
[1] Calif Dept Publ Hlth, Genet Dis Screening Program, Richmond, CA 94804 USA
[2] Publ Hlth Fdn Enterprises, City Of Industry, CA USA
关键词
newborn screening; surveillance; metabolic disorders; follow-up; TANDEM MASS-SPECTROMETRY; INBORN-ERRORS; PROGRAMS; METABOLISM; DISORDERS;
D O I
10.1097/GIM.0b013e3181fe5d66
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: State newborn screening programs are designed to prevent morbidity and mortality from hereditary disorders through early detection and ongoing disease management. These programs have traditionally focused on short-term follow-up. However, capturing data on the long-term follow-up process is emerging as a new priority. Long-term follow-up data can be used to assess the accessibility, continuity, and quality of care provided to these children. The California Newborn Screening Program uses a Web-based data collection system for short- and long-term follow-up. This article provides a description of the follow-up data collection system in addition to preliminary findings to demonstrate the efficacy of the California data collection approach. Methods: A preliminary analysis of short-term follow-up data collected from July 7, 2005, through April 30, 2009, and a preliminary analysis of long-term follow-up data collected from July 1, 2007, through April 30, 2009. Results: A majority of children are able to access ongoing care through age 5 years. The majority also have positive health outcomes at each year of follow-up. Conclusion: California's short- and long-term data collection system can serve as a model for other states interested in implementing a comprehensive Newborn Screening Program follow-up data system. Genet Med 2010:12(12):S242-S250.
引用
收藏
页码:S242 / S250
页数:9
相关论文
共 23 条
[1]  
*AMCHP, 2007, NEWB SCREEN LONG TER
[2]   Developing a National Registry for conditions identifiable through newborn screening [J].
Botkin, Jeffrey R. ;
Anderson, Rebecca ;
Staes, Catherine ;
Longo, Nicola .
GENETICS IN MEDICINE, 2009, 11 (03) :176-182
[3]   SIDS and disorders of fatty acid oxidation: Where do we go from here? [J].
Cederbaum, SD .
JOURNAL OF PEDIATRICS, 1998, 132 (06) :913-914
[4]  
Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P1012
[5]   Tandem mass spectrometry program implementation challenges for state newborn screening programs: National survey of barriers and issues [J].
Feuchtbaum, L ;
Faulkner, L ;
Verghese, S .
PEDIATRICS, 2006, 117 (05) :S253-S260
[6]   The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: An update [J].
Grosse, SD ;
Khoury, MJ ;
Greene, CL ;
Crider, KS ;
Pollitt, RJ .
GENETICS IN MEDICINE, 2006, 8 (04) :205-212
[7]   Newborn dried bloodspot screening: mapping the clinical and public health components and activities [J].
Hinman, Alan R. ;
Mann, Marie Y. ;
Singh, Rani H. .
GENETICS IN MEDICINE, 2009, 11 (06) :418-424
[8]   Long-term follow-up culture in state newborn screening programs [J].
Hoff, Timothy .
GENETICS IN MEDICINE, 2008, 10 (06) :396-403
[9]   Long-term follow-up data collection and use in state newborn screening programs [J].
Hoff, Timothy ;
Ayoob, Maria ;
Therrell, Bradford L. .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2007, 161 (10) :994-1000
[10]   Practices and perceptions of long-term follow-up among state newborn screening programs [J].
Hoff, Timothy ;
Hoyt, Adrienne .
PEDIATRICS, 2006, 117 (06) :1922-1929